New research presented at this year’s European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new GLP-1 class of obesity drugs in people […]
A recent study shows that the rapid increase of new nicotine products and the influence of the tobacco industry are perceived to significantly hinder the European countries’ ability […]
Treatment with CGRP inhibitors, a class of drugs used to prevent migraine, appears to be associated with a reduced risk of glaucoma, researchers reported on May 6, 2026 […]
A new meta-analysis of relevant clinical studies suggests that GLP 1 weight-loss drugs provide protection against heart attacks, strokes and premature death for up to 2.7 years. The […]
For years, a central debate in tobacco policy has been whether taxing e-cigarettes (ECs) might unintentionally drive vapers back to traditional cigarettes. A new study published in Health Economics suggests […]
Researchers presenting at the American Geriatrics Society (AGS) Virtual Annual Scientific Meeting (#AGS26), taking place April 30th – May 2nd (pre-conference days Monday, April 27th – Wednesday, April 29th), represent the leading […]
Flu vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people who get infected after getting the vaccine, according to research published in […]
While cigarette exposures are decreasing for young children, electronic nicotine products are putting toddlers at new risk of inhalation, according to Rutgers Health researchers. Their study, published in JAMA Network […]
A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)—including antidepressants—may be associated with a small but measurable […]
A new overview of the best available evidence worldwide for smoking cessation has found that nicotine‑containing e‑cigarettes appear to be more effective for smoking cessation than other interventions […]
People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and […]
Nearly 1 in 2 Americans has high blood pressure—sometimes called the “silent killer” because it harms the heart and blood vessels—but many people don’t know they have it. […]
ADVERTISMENT
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
